Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Aurinia Pharmaceuticals Inc, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aurinia Pharmaceuticals Inc June 14, 202445.7%
-
Aurinia Pharmaceuticals Inc May 17, 202357.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2024 | Aurinia Pharmaceuticals Inc | Open-market sale | −5,630 | $5.74 | $32,316 |
| May 23, 2023 | Aurinia Pharmaceuticals Inc | Open-market sale | −4,818 | $11.26 | $54,251 |
| May 19, 2023 | Aurinia Pharmaceuticals Inc | Grant or award | +9,310 | — | — |
| May 18, 2023 | Aurinia Pharmaceuticals Inc | Option exercise | +8,733 | — | — |
Questions about R. Hector MacKay-Dunn
What boards is R. Hector MacKay-Dunn on?
R. Hector MacKay-Dunn sits on the board of Aurinia Pharmaceuticals Inc.
How long has R. Hector MacKay-Dunn served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.